DOHA: The Supreme Council of Health (SCH) has ordered a recall of two batches of Panadol Baby and Infant Suspension (100ml) from the local market. The Pharmacy and Drug Control Department at SCH said yesterday that it has issued a circular to all pharmacies to withdraw the batches N0 66 and N143. The recall is due to an error in the doses mentioned in the external package of the products which are manufactured by GlaxoSmithKline (GSK), a leading global healthcare company. The SCH, however, said there are no issues related to quality of the products and alternative products are available in the market. The Peninsula
